Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jun;30(6):909-910.
doi: 10.1681/ASN.2019040333. Epub 2019 May 13.

Dual Inhibition of Gastrointestinal Phosphate Absorption: More Questions Than Answers

Wing-Chi G Yeung  1 , Nigel D Toussaint  2   3 , Sunil V Badve  4   5
Affiliations
Editorial

Dual Inhibition of Gastrointestinal Phosphate Absorption: More Questions Than Answers

Wing-Chi G Yeung et al. J Am Soc Nephrol. 2019 Jun.
No abstract available

Keywords: chronic kidney disease; phosphate binders; randomized controlled trials.

PubMed Disclaimer

Comment on

References

    1. Toussaint ND, Pedagogos E, Tan SJ, Badve SV, Hawley CM, Perkovic V, et al. : Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk. Nephrology (Carlton) 17: 433–444, 2012 - PubMed
    1. Ix JH, Shlipak MG, Wassel CL, Whooley MA: Fibroblast growth factor-23 and early decrements in kidney function: The heart and soul study. Nephrol Dial Transplant 25: 993–997, 2010 - PMC - PubMed
    1. Wolf M: Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21: 1427–1435, 2010 - PubMed
    1. Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, et al. : Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23: 1407–1415, 2012 - PMC - PubMed
    1. Chue CD, Townend JN, Moody WE, Zehnder D, Wall NA, Harper L, et al. : Cardiovascular effects of sevelamer in stage 3 CKD. J Am Soc Nephrol 24: 842–852, 2013 - PMC - PubMed